Description

The Hepatic Fibrosis Test YRA317 and YRA321 are designed to enable early detection and monitoring of liver fibrosis, which is crucial in preventing the more severe progression to cirrhosis. These tests are compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, ensuring accuracy and reliability. Early intervention can significantly improve a patient’s quality of life and prognosis. These tests analyze key parameters like PIIINP and CG, giving a comprehensive overview of hepatic health.

Market Price

Hepatic fibrosis tests like YRA317 and YRA321 typically fall into a range that can vary based on region, supplier, and the quantity purchased. However, they usually range from $200 to $500 per box. To get the best deal, we recommend requesting a quotation through our Kalstein Plus platform, ensuring you get competitive pricing and superior service.

Frequently Asked Questions

What is the shelf life of the Hepatic Fibrosis Test kits? These kits are designed to be stable when stored at 2-8°C, ensuring optimal condition until the expiration date provided on the packaging.

Can these tests be used with any other equipment? The Hepatic Fibrosis Tests YRA317 and YRA321 are specifically optimized for use with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390 for best results.

Advantages and Disadvantages

The primary advantage of these tests is their ability to provide early detection of liver fibrosis, which can be pivotal for effective treatment and management. They also offer compatibility with advanced analyzers and comply with high certification standards like CE and ISO13485. A potential disadvantage is the necessity for specific equipment, which may limit use to facilities with the appropriate analyzers.

Field Use

In practice, these tests are used in hospitals and laboratories where accurate monitoring of liver health is key. Their application is valuable in patient populations at risk of liver damage due to conditions such as hepatitis or alcohol use. The results aid clinicians in crafting targeted treatment regimens to address and manage liver fibrosis effectively.

Recommendations

To maximize the benefit of the Hepatic Fibrosis Test, ensure proper storage conditions and follow the equipment compatibility guidelines strictly. Regular calibration and maintenance of the Chemiluminescence Immunoassay Analyzers will help maintain accuracy. Utilize the results to adjust treatment plans accordingly, and always seek further professional medical advice when necessary. For a seamless purchasing experience, visit our Kalstein Plus platform to generate a quick and easy quote.

Features

• Early detection and monitoring of liver fibrosis.
• Compatibility with YR06389 and YR06390 analyzers.
• CE, ISO13485, and FSC certified.
• Comprehensive parameter analysis including PIIINP, CIV, LN, HA, and CG.

Technical Specifications